| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |